Evofem Biosciences logo

Evofem Biosciences Funding & Investors

Evofem Biosciences, Inc. operates as a clinical-stage specialty biopharmaceutical company. The Company focuses on women's medical needs through development and commercialization of women's healthcare products. Evofem Biosciences develops therapeutic solutions to meet sexual and reproductive health needs. Evofem Biosciences serves patients in the United States.

evofem.com

Total Amount Raised: $175,300,000

Evofem Biosciences Funding Rounds

  • Post Ipo Equity

    $10,000,000

    Post Ipo Equity Investors

    Keystone Capital
  • Post Ipo Debt

    $25,000,000

    Post Ipo Debt Investors

    Adjuvant Capital
  • Post Ipo Equity

    $50,000,000

    Post Ipo Equity Investors

    Pdl Biopharma
  • Post Ipo Equity

    $30,000,000

    Post Ipo Equity Investors

    Pdl Biopharma
  • Post Ipo Equity

    $25,000,000

    Post Ipo Equity Investors

    Woodford Investment Management
  • Series C

    $8,000,000

    Series C Investors

    Alta Partners
    AK Capital
    Domain Associates
  • Series C

    $6,700,000

    Series C Investors

    RUSNANO
    Mirae Asset Venture Investment
  • Series C

    $20,600,000

    Series C Investors

    RUSNANO
    AMOREPACIFIC Ventures
    Domain Associates
    Numoda Capital Innovations
    Alta Partners
    RMI Partners
  • IPO

    Unknown

Funding info provided by Diffbot.